Evidence map›Paper›PMID 35097306›Full record

ArticleACS omega2022

GANE can Improve Lung Fibrosis by Reducing Inflammation via Promoting p38MAPK/TGF-β1/NF-κB Signaling Pathway Downregulation.

Ebtesam A Mohamad, Zahraa N Mohamed, Mohammed A Hussein, Mona S Elneklawi

Open access · goldAbstract read
In one paragraph

Article in ACS omega, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cardioprotective Potential ofCurrent pharmaceutical biotechnology · 2025
    Article
  12. Review
  13. Optimization of Phloretin-loaded Nanospanlastics for Targeting ofCurrent pharmaceutical biotechnology · 2024
    Article
  14. Current pharmaceutical biotechnology · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. ACS omega · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ebtesam A MohamadBiophysics Department, Faculty of Science, Cairo University, Cairo University Street, Giza 12613, Egypt.
Zahraa N MohamedMedical Laboratory Department, Faculty of Applied Medical Sciences, October 6 University, 6th of October City 28125, Giza, Egypt.
Mohammed A HusseinBiochemistry Department, Faculty of Applied Medical Sciences, October 6 University, 6th of October City 28125, Giza, Egypt.ORCID https://orcid.org/0000-0002-1811-2794
Mona S ElneklawiBiomedical Equipment Department, Faculty of Applied Medical Sciences, October 6 University, 6th of October City 28125, Giza, Egypt.
October 6 University · EGCairo University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a trend to use nanoparticles as distinct treatments for cancer treatment because they have overcome many of the limitations of traditional drug delivery systems. Gallic acid (GA) is an effective polyphenol in the treatment of tissue injuries. In this study, GA was loaded onto niosomes to produce gallic acid nanoemulsion (GANE) using a green synthesis technique. GANE's efficiency, morphology, UV absorption, release, and Fourier-transform infrared spectroscopy (FTIR) analysis were evaluated. An

Identifiers

PMID35097306
PMCPMC8792938
OpenAlexW4206487853

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.